PharmaBoardroom

The Impact of Next Generation Sequencing on Women-Focused Cancers

Kamala Maddali, vice president for Biopharma Collaborations & Companion Diagnostics at Cancer Genetics, discusses what impact next generation…

NEW France Pharma Report Out Now!

France is rediscovering its mojo. After a period of relative stagnation, the country’s highly strategic USD 65 billion healthcare and life sciences…

Generics: Pioneered by Women

As part of Women’s History Month, Chip Davis, president and CEO of the Association for Accessible Medicines highlights some of the most outstanding…

Stella Yoon – Managing Director, French-Korean Chamber of…

The French-Korean Chamber of Commerce and Industry (FKCCI) has grown rapidly in the last decade, both in terms of members and revenues. Its managing…

Emad Graiss – Managing Director, Merck North East Africa

Emad Graiss, managing director of Merck North East Africa, explains what it takes to successfully steer a company through a period of economic…

YongBum Choi – General Manager, Ferring Korea

YongBum Choi, general manager of Ferring Korea, explains how he plans to foster the Ferring values in the local affiliate. Mr Choi also breaks down…

Jean-Marc Grognet – General Manager, Genopole, France

Jean-Marc Grognet, general manager of Genopole, France’s leading biotechnology cluster, explains the organization’s unique triangular structure…

Jung Yun Taek – President & CEO, PSI, South Korea

The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal…

Jean-Louis Anspach – General Manager, Teva France

Jean-Louis Anspach, general manager of Teva France, elaborates on the affiliate’s transitional restructuring period as they make a turnaround effort…

James Jungkue Lee – Founder & CEO, Bridge…

James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also…

Mohamed Swilam – Country Manager, Roche Egypt

Mohamed Swilam, country manager of Roche Egypt, explains how ensuring access to medicine in Egypt is not only related to pricing challenges, but also…

The Technology Driving Rare Disease Pipelines

Rhenu Buller, an expert on disruptive technologies at business consultancy Frost & Sullivan's Asia Pacific office, outlines the technological…

Tagged with R